Dolby Laboratories (DLB) Set to Announce Quarterly Earnings on Monday

Dolby Laboratories (NYSE:DLB) will issue its quarterly earnings data after the market closes on Monday, August 3rd. Analysts expect the company to announce earnings of $0.13 per share for the quarter. Dolby Laboratories has set its Q3 2020
After-Hours guidance at 0.18-0.35 EPS and its Q3 guidance at $0.18-0.35 EPS.Parties that are interested in registering for the company’s conference call can do so using this link.

Dolby Laboratories (NYSE:DLB) last announced its earnings results on Monday, May 4th. The electronics maker reported $1.04 earnings per share for the quarter, missing the consensus estimate of $1.09 by ($0.05). The business had revenue of $351.82 million for the quarter, compared to the consensus estimate of $361.35 million. Dolby Laboratories had a net margin of 17.74% and a return on equity of 9.45%. The firm’s revenue was up 4.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.04 EPS. On average, analysts expect Dolby Laboratories to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Shares of Dolby Laboratories stock opened at $69.60 on Friday. The business’s fifty day moving average price is $66.18 and its two-hundred day moving average price is $63.11. The company has a market capitalization of $6.95 billion, a P/E ratio of 32.25, a PEG ratio of 3.19 and a beta of 0.88. Dolby Laboratories has a 1-year low of $44.68 and a 1-year high of $73.20.

DLB has been the topic of several recent analyst reports. Zacks Investment Research downgraded Dolby Laboratories from a “hold” rating to a “sell” rating and set a $61.00 target price on the stock. in a research note on Monday, May 11th. TheStreet upgraded Dolby Laboratories from a “c+” rating to a “b-” rating in a research report on Monday, June 15th. JPMorgan Chase & Co. lowered their price target on Dolby Laboratories from $66.00 to $65.00 and set an “overweight” rating on the stock in a research report on Tuesday, May 5th. Finally, B. Riley cut Dolby Laboratories from a “buy” rating to a “neutral” rating and lifted their price target for the company from $68.00 to $72.00 in a research report on Wednesday, June 24th. They noted that the move was a valuation call. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and five have given a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $67.00.

In related news, CEO Kevin J. Yeaman sold 50,000 shares of Dolby Laboratories stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $60.00, for a total value of $3,000,000.00. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Lewis Chew sold 10,000 shares of Dolby Laboratories stock in a transaction on Wednesday, May 13th. The stock was sold at an average price of $54.79, for a total value of $547,900.00. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 64,167 shares of company stock worth $3,837,507. 38.17% of the stock is owned by insiders.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment and communications at the cinema, at home, at work, and on mobile devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for TVs, set-top boxes (STBs), personal computers (PCs), gaming consoles, mobile devices, and digital radio; AVC, a digital video codec with high bandwidth efficiency used in media devices; Dolby AC-4, an audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for home theaters, cinemas, device speakers, mobile devices, and headphones.

Further Reading: Why do corrections happen?

Earnings History for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.